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a b s t r a c t
Background: Exposure to traffic-related air pollutants, including polycyclic aromatic hydrocarbons
(PAHs) from traffic emissions and other combustion sources, and childhood obesity, have been
implicated as risk factors for developing asthma. However, the interaction between these two on asthma
among young urban children has not been studied previously.
Methods: Exposure to early childhood PAHs was measured by two week residential indoor monitoring at
age 5–6 years in the Columbia Center for Children's Environmental Health birth cohort (n¼311).
Semivolatile [e.g., methylphenanthrenes] and nonvolatile [e.g., benzo(a)pyrene] PAHs were monitored.
Obesity at age 5 was defined as a body mass index (BMI) greater than or equal to the 95th percentile of
the year 2000 age- and sex-specific growth charts (Center for Disease Control). Current asthma and
recent wheeze at ages 5 and 7 were determined by validated questionnaires. Data were analyzed using a
modified Poisson regression in generalized estimating equations (GEE) to estimate relative risks (RR),
after adjusting for potential covariates.
Results: Neither PAH concentrations or obesity had a main effect on asthma or recent wheeze. In models
stratified by presence/absence of obesity, a significant positive association was observed between an
interquartile range (IQR) increase in natural log-transformed 1-methylphenanthrene (RR [95% CI]: 2.62
[1.17–5.88] with IQRln¼0.76), and 9-methylphenanthrene (2.92 [1.09–7.82] with IQRln¼0.73) concentra-
tions and asthma in obese children (n¼63). No association in non-obese (n¼248) children was observed
at age 5 (Pinteractiono0.03). Similar associations were observed for 3-methylphenanthrene, 9-methyl-
phenanthrene, and 3,6-dimethylphenanthrene at age 7.
Conclusions: Obese young children may be more likely to develop asthma in association with greater
exposure to PAHs, and methylphenanthrenes in particular, than non-obese children.
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1. Introduction
The prevalence of childhood obesity has increased from 7%
to 20% from 1980–2008 in the United States, and is higher for
Hispanics (31%) and Blacks (23%) in New York City (NYC) (Thorpe
et al., 2004). Concomitant with the rapid rise in childhood obesity,
the prevalence of childhood asthma also has increased from 3.6% to
9.6% during 1980–2009 (Akinbami et al., 2009; CDC, 2011), espe-
cially in urban areas like NYC (Nicholas et al., 2005).
Exposure to air pollution, and polycyclic aromatic hydrocarbons
(PAHs) in particular, appears to be a risk factor for the development
of asthma in urban settings (Jung et al., 2012b; Miller et al., 2004). For
example, our previous study reported that repeated high exposure to
PAHs, semivolatile pyrene specifically, during prenatal period and age
5–6 years, is associated with asthma in young children (Jung et al.,
2012b). Obesity also has been associated with the development of
childhood asthma in both cross-sectional and prospective studies
(Castro-Rodriguez et al., 2001; Gilliland et al., 2003; Visness et al.,
2010). Further, the asthma-obesity association may vary by sex or
atopic status (Castro-Rodriguez et al., 2001; Gilliland et al., 2003;
Visness et al., 2010). For example, a study in the Tucson, Arizona
cohort found that becoming overweight or obese between the ages
of 6 and 11 years increased the risk of developing new wheeze at age
11 or 13 among girls but not boys (Castro-Rodriguez et al., 2001).
However, a subsequent prospective study of school-age children in
South California found that being overweight or obese was associated
with an increased risk of incident asthma in boys, but not in girls; the
strongest effect was observed among nonatopic boys (Gilliland et al.,
2003). One study using the National Health and Nutrition Examina-
tion Survey (NHANES) data set (1999–2006) also found that obesity
was associated with current asthma among children ages 2–19, with
a stronger association in nonatopic children (Visness et al., 2010).
Emerging evidence suggests that the presence of obesity may
modify the effects of exposure to air pollution on respiratory disease.
For example, obese individuals experienced a greater decline in forced
expiratory volume in 1 s (FEV1) following ozone (O3) exposure,
compared to nonobese subjects (Alexeeff et al., 2007). This finding
was supported by animal studies showing that genetically (db/db
mice lacking leptin receptor) or diet-induced obese mice exhibi-
ted increased airway hyperresponsiveness (AHR) and enhanced O3-
induced pulmonary inflammation (e.g., greater interleukin (IL)-6
production) compared to nonobese mice (Johnston et al., 2008; Lu
et al., 2006). These results suggest that obesity may confer greater
vulnerability in airways following exposure to some air pollutants, yet
the role of obesity following exposure to PAH on childhood asthma
has not been studied previously.
PAHs have 2 types of anthropogenic sources: pyrogenic (i.e.,
incomplete combustion of organic material such as from traffic
emissions and heating oil combustion) and petrogenic (e.g., unburned
fossil organic material contribution such as direct evaporations from
petroleum products). Alkylated PAHs (e.g., methylphenanthrenes), as
opposed to parent PAHs (e.g., phenanthrene), are emitted more
abundantly from petrogenic than pyrogenic sources (Saha et al.,
2009). The toxicities of the individual phenanthrenes and methyla-
phenanthrenes during in vivo experiments are known to differ
(Wolinska et al., 2011). While our earlier study suggests that repeated
high exposure to unsubstituted semivolatile PAHs (i.e., pyrene) may
induce asthma (Jung et al., 2012b), our understanding of the effects of
exposure to alkylated PAHs (e.g., methylphenanthrenes) on respira-
tory health is more limited.
The goal of this study was to examine whether obesity may
modify the effects of age 5–6 years PAH exposure, and semivolatile
and alkylated PAHs in particular, on asthma in 5–7 years old inner-
city children living in Northern Manhattan and the Bronx. Under
the auspices of the Columbia Center for Children's Environmental
Health (CCCEH) birth cohort, we were able to control for prenatal
PAH concentrations and exposure to other indoor air pollutants
such as fine particulate matter (PM2.5) and soot/black carbon (BC).
We hypothesized that obese children would be at greater risk of
having asthma and recent wheeze with exposure to higher PAH
than would non-obese children.
2. Methods
2.1. Study population
727 healthy and nonsmoking Dominican or African American mothers who
reside in Northern Manhattan or South Bronx were enrolled into the CCCEH cohort
during pregnancy (Miller et al., 2004). Questionnaires were administrated to the
mother prenatally, every 3 months through age 2 years, and every 6 months
thereafter. PAH concentrations were measured from residential indoor monitors for
408 of their children at age 5–6 years. Data were analyzed for those children
(n¼363) for whom measures of indoor PAH measures at age 5–6, height and
weight, and complete age 5 questionnaire data were available. The study was
approved by the Columbia University Institutional Review Board and written
informed consent was obtained from all study participants.
2.2. Air monitoring
Details of residential air monitoring have been published previously (Jung et al.,
2010a). Indoor air monitors were placed in a roomwhere the child spent most of his
or her time for two weeks between 2005 and 2011 at age 5 through 6. Sixteen 3-ring
to 6-ring PAH (eight semivolatile (178rMWr206) and eight nonvolatile
(228rMWr278) PAH; see Supplementary material) were selected as target
compounds due to their abundance in traffic emissions and their possible carcino-
genicity and mutagenicity (Jung et al., 2010b). Nine of these PAHs (eight nonvolatile
PAHs and pyrene) also had been measured prenatally using 48-hr personal air
monitor-
ing between 1998 and 2006 (Miller et al., 2004). A single soxhlet extraction of both
the filter and PUF together was analyzed for PAHs at Southwest Research Institute as
described (Jung et al., 2010a, 2010b; Miller et al., 2004).
Residential indoor levels of PM2.5 and BC were measured simultaneously with
PAH monitoring, with a repeat sampling 6 months later. Details of analytical
protocols for PM2.5 and BC are described in Jung et al. (2010a, 2010b).
2.3. Obesity
Child's height and weight were measured at age 5, using a SECA wall-mounted
stadiometer (SECA, Hamburg, Germany) and a Detecto Cardinal 750 digital scale
(Cardinal Scale Manufacturing Company, Webby City, Missouri), respectively (Rundle
et al., 2012). Children's body mass index (BMI; defined as weight in kilograms divided
by height in meters squared (kg/m²)) z scores and percentiles were calculated using
the Centers for Disease Control (CDC) and Prevention SAS macro (Prevention, 2004). A
child was classified as obese if the BMI was greater than or equal to the age- and sex-
specific 95th percentile of the year 2000 CDC growth charts.
2.4. Health outcomes
The Brief Respiratory Questionnaires (BRQ) (Bonner et al., 2006) was used to
assess current asthma, defined as parental report of doctor diagnosis of ever
asthma AND a report of asthma medication use in the past 12 months. International
Study of Asthma and Allergies in Childhood questionnaires (ISAAC) (Jenkins et al.,
1996) was used to assess recent wheeze, defined as any report of wheeze in the last
12 months.
2.5. Seroatopy
Total and specific immunoglobulin (Ig)E to cat, mouse, dog, Dermatophagoides
farinae and German cockroach at age 5 were measured in duplicate from sera using
Immunocap (Phadia, Uppsala, Sweden) as described (Donohue et al., 2008).
Children were considered sensitized to indoor allergens if they had a specific
IgEZ0.35 IU/mL to any of the allergens tested. They were classified as having any
allergic sensitization if total IgEZ50 IU/mL. Children were defined as seroatopic
if they met either of these criteria.
2.6. Statistical analysis
Age 5–6 years PAH were natural log-transformed to normalize skewed distribu-
tions (e-Fig. 1). As reported previously (Jung et al., 2010a), PAH were analyzed as
individual PAH, the sum of eight semivolatile PAH (Σ8PAHsemivolatile), and the sum of
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8 nonvolatile PAH (Σ8PAHnonvolatile) due to the absence of correlations between
semivolatile and nonvolatile PAH (e-Table 1). Relative risks (RR) are presented for an
interquartile range (IQR) increase in each natural log-transformed PAH concentra-
tion. The associations among levels of age 5–6 years PAH, obesity and respiratory
outcomes were analyzed in several ways using a modified Poisson regression in
generalized estimating equations (GEE) to estimate RR (Zou, 2004). First, the models
were adjusted for common potential covariates, including maternal race/ethnicity,
sex, maternal asthma, maternal education, prenatal environmental tobacco smoke
(ETS) exposure, any reported postnatal ETS exposure at 6, 12, 24, 36, and 60 months,
and cold/influenza season. Dichotomous variables indicating seroatopic to indoor
allergens, whether the residential monitoring was conducted at age 5 vs. 6 years, and
season of childhood PAH measurement (heating season [October–April] vs. non-
heating season [May–September]) also were controlled in the model. Further, natural
log-transformed prenatal measures of PAH, that were minimally or not correlated
with measures of PAH at age 5–6 years, and natural log of the average of repeat
indoor measurements of PM2.5 and BC were included in the model (adjusted model).
Second, the subjects were stratified by obesity status and the adjusted models were
run within each stratum (stratified model). Third, a multiplicative interaction term
was included in the adjusted models (interaction model) to test whether the
association between age 5 and 6 years PAH concentration and respiratory outcomes
significantly varied by obesity status. The relative excess risk due to interaction
(RERI) was estimated further by testing a departure from additivity with its 95%
confidence intervals from percentiles of 10,000 bootstrap samples.
Secondary analyses were conducted with the tertiles of age 5–6 PAH concen-
trations (the second [middle] and third [highest] vs. the first [lowest] as reference).
Additional analyses were conducted to test the multiplicative interaction term for
effect modification by obesity after stratifying by seroatopy and sex.
Sensitivity analyses were conducted as follows: (1) reanalysis after excluding
children (n¼81) with an existing reported doctor diagnosed asthma at 36, 48, or 54
months, (2) reanalysis after substituting overweight (BMIZ85th percentile) for obese
and using BMI z score, (3) reanalysis after controlling for pre-pregnancy maternal BMI,
and (4) reanalysis after eliminating upper or lower 5% of age 5–6 years PAH measures
or removing children (n¼19) who took inhaled corticosteroids (ICS) in the last
3 months. All analyses were performed using PASW Statistic version 18.0 (SPSS Inc.,
Chicago, IL, USA) where po0.05 was considered statistically significant.
3. Results
3.1. Cohort characteristics
Children who had residential air monitoring, and BMI data
available, and completed questionnaires at age 5 did not differ
demographically from CCCEH children excluded from the current
analyses (i.e, missing residential measures, BMI or health outcome
data due to age-related inclusion criteria; Table 1), with the excep-
tion of a slightly higher frequency of any allergic sensitization (i.e.
total IgEZ50 IU/mL [χ2 test; p¼0.02]). Seventy two percent (224/
311) of residential air samples were collected at age 5 instead of age
6 (Table 1). Of the 408 childrenwith PAHmeasurements, 97 children
were dropped from the analysis due to missing covariates or invalid
air pollution data, resulting in a final sample of 311 (Fig. 1).
3.2. Age 5–6 years PAH concentrations, obesity, and asthma
Descriptive statistics of age 5–6 years PAH concentrations are
shown in e-Table 2, with 100% above limit of detection (LOD) of
semivolatile PAH. Phenanthrene, the most abundant compound
among the measured individual PAH (72% of total sum of 16 PAH;
e-Table 2) correlated strongly with concentrations of all other
semivolatile PAH (e-Table 1. Pearson correlation 0.46rrr0.78)
but not with Σ8PAHnonvolatile (r¼0.06).
Levels of Σ8PAHnonvolatile or semivolatile PAH alone were not
associated directly with asthma or recent wheeze in adjusted
models (Tables 2, p40.05), consistent with our previous findings
(Jung et al., 2012b; Miller et al., 2004). Also, in adjusted models
childhood obesity was not significantly associated with asthma or
wheeze (p40.05).
3.3. Effect modification of the association between age 5-6 years PAH
concentrations and asthma by obesity
Among 63 obese children, higher levels of 1-methylphenanthrene
(Fig. 2; RR [95% CI]: 2.62 [1.17–5.88]), 9-methylphenanthrene (2.17
[1.06–4.45]), and 3,6-dimethylphenanthrene (2.69 [1.21–5.94]) were
associated with asthma at age 5 years, after controlling for common
covariates and air pollutants (prenatal PAH, age 5–6 years PM2.5 and
BC measures). These findings were not replicated when examining the
associations between the other semivolatile PAH or Σ8PAHnonvolatile
and asthma or wheeze among obese children (Table 2; data not
shown for wheeze). Among 248 non-obese children, significant
associations were not found between any PAH levels and asthma
and wheeze (Table 2; data not shown for wheeze).
In the interaction model, a significant interaction between several
semivolatile PAH levels (i.e., 1-methylphenanthrene, 9-methylphena-
nthrene and pyrene) and obesity on asthma at age 5 was found
(Table 2, Pinteractiono0.03). Consistently, a significantly greater than
additive interaction was observed using the RERI (Supplementary
material). In comparison, obesity showed no effect modification of the
association between any PAH and recent wheeze (all Pinteraction40.05;
data not shown).
Secondary analyses were conducted to assess the stability of
the associations between age 5-6 years PAH exposure, obesity and
asthma at age 7. Higher levels of 3-methylphenanthrene (Fig. 3, RR
[95% CI]: 3.25 [1.45–7.27]), 9-methylphenanthrene (5.12 [1.87–14.1]),
and 3,6-dimethylphenanthrene (3.28 [1.40–7.71]) were associated
with asthma in obese, but not non-obese 7 years olds (Pinteraction¼0.01,
Pinteractiono0.001 and Pinteraction¼0.005 for 3-methylphenanthrene,
9-methylphenanthrene and 3.6-dimethylphenanthrene, respectively).
Similar associations were found when PAH levels were categorized by
tertiles. Among obese, but not non-obese children, the highest tertiles
of 9-methylphenanthrene and 3,6-dimethylphenanthrene, as com-
pared with the lowest, were significantly associated with asthma
at both ages 5 and 7 years (e-Table 3; data not shown for age 7).
The second tertiles, but not the third tertiles of phenanthrene,
1-methylphenenthrene, 2-methylphenanthrene, and Σ8PAHsemivolatile
were associated with higher relative risks of asthma at age 5 years (e-
Table 3).
In addition, to explore whether these associations vary by asthma
phenotype (e.g., seroatopic vs. nonatopic) or sex (girls vs. boys),
interaction analyses were repeated following stratification by seroa-
topy (elevated indoor specific allergen or total IgE) and sex. Among
the non-seroatopic children, the interaction between obesity and all
the semivolatile PAH except 1,7-dimethylphenanthrene became sig-
nificant or borderline significant for asthma and wheeze (e-Table 4;
Pinteractiono0.05 for all). In addition, a significant positive interaction
was found between 1-methylphenanthrenes and 1,7-dimethylphe-
nanthrene and obesity on asthma in girls, but not boys (e-Table 5;
Pinteractiono0.01).
3.4. Sensitivity analyses
First, a significant interaction was replicated for all PAH, except
pyrene and Σ8PAHnonvolatile at age 5 when the analyses were
restricted to those without a preexisting doctor diagnosed asthma
at 36, 48 or 54 months (e-Table 6; Pinteractiono0.05). Second,
analyses for interactions were repeated for age 5-6 PAHs using
overweight, defined as BMIZ85th percentile, or using a contin-
uous BMI z score. The interaction between phenanthrene and
overweight reached significance for asthma (Pinteraction¼0.03),
while the interactions for other semivolatile PAH were not
statistically significant. When obesity was replaced with BMI z
score, a significant interaction was replicated for all PAH, except
1,7-dimethlyphenanthrene, pyrene and Σ8PAHnonvolatile at ages
5 and 7 years (Table 3). After adjustment for maternal BMI, the
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effect modification by obesity remained at both age 5 and 7 (e.g.,
RR [95% CI] for 1-methylphenanthrene: 2.73 [1.09–6.79] in obese
but not non-obese 5 years old with Pinteraction¼0.004). There were
modest effect modifications of the association between asthma
and 1-methylphenanthrnee, 3,6-dimethylphenanthrene, and pyr-
ene by obesity after the exclusion of the upper or lower 5% of
measures (Pinteractiono0.10). Lastly, after removing those who took
inhaled corticosteroids (n¼19), the associations displayed in
Figs. 2 and 3 remained, with a smaller RR (e-Fig. 1).
4. Discussion
We found that higher concentrations of age 5–6 methylphe-
nanthrenes were associated with asthma among obese children,
but not non-obese children, at ages 5 and 7 years. This is the first
study to report that obesity modified the effect of age 5–6 years
PAH concentrations on asthma in an urban cohort of young
children.
The strengths of the study include its ability to control key risk
factors for childhood asthma development such as seroatopy and
prenatal PAH concentrations. The prenatal period is an important
time window of exposure that may affect children's respiratory
health and obesity in later life (Miller et al., 2004; Rundle et al.,
2012). Another was the direct measurement of each child's
exposure based on two-week integrated home indoor samples.
Our previous studies showed that PAH levels, measured in the
sequential two-week residential indoor samples over 6–8 weeks of
sampling periods, are relatively stable and highly correleated with
each other (Rundle et al., 2012), implying that a single measure of
two-week averaged PAH levels may be considered an indicator
of longer-term exposure at age 5–6 years. We also controlled for
the association of other indoor air pollutants such as PM2.5 and
BC, previously associated with an increased risk of developing
new wheeze among children aged 5–7 years in our cohort (Jung
et al., 2012a).
We suspect substantial indoor emissions as the main sources
of these semivolatile PAH (Jung et al., 2010a). These may include
cigarette smoking, incense burning/candling, cooking and space
heating (Gustafson et al., 2008; Jung et al., 2010a), and evaporation
from petrochemicals used indoors such as hair spray, deodorant,
hand lotion, shampoo, perfumes, vinyl siding, floor polish, shower
curtains, insect repellent, and pesticides (Greeniacs, 2012). Certainly
infiltration of outdoor-originated semivolatile PAH from petrogenic
and pyrogenic emissions related to traffic and heating sources may
contribute to the indoor measures as well (Jung et al., 2010a).
The primary finding suggests that obesity modifies the effects
of age 5–6 years PAH exposure on asthma at age 5. We previously
reported that age 5–6 years PAH concentrations, only when
combined with high prenatal PAH measures, was associated with
asthma among young children, suggesting that age 5–6 years PAH
exposure alone is not a risk factor for adverse respiratory health.
Additionally, a large body of epidemiologic data suggests that
obesity is a risk factor for asthma (Castro-Rodriguez et al., 2001;
Gilliland et al., 2003; Visness et al., 2010). Thus, these evidences
lend support to the hypothesis that exposure to PAH and child-
hood obesity may have additive or synergistic effects on develop-
ing or worsening asthma. After controlling for prenatal PAH
concentrations and other indoor air pollutants, we found that
the risk of developing asthma increased with higher levels of
methylphenanthrenes among obese, but not non-obese children,
suggesting a synergistic effect of methylphenanthrenes and obe-
sity. Significant interactions were replicated in an adjusted analy-
sis controlling for maternal BMI, which previously was reported to
Table 1
Demographic characteristic of the study cohort [No. (%)]a.
Characteristic Subjects includedb N¼311 Subjects excludedc N¼416
N/total [%] N/total [%]
Maternal ethnicity
Dominican 193/311 [62] 280/416 [67]
African–American 118/311 [38] 136/416 [33]
Girls 164/311 [53] 212/416 [51]
Maternal high school or greater degree 193/311 [62] 263/402 [65]
Maternal asthma (þ) 77/311 [25] 86/416 [21]
Prenatal ETS exposured (þ) 100/311 [32] 146/406 [36]
Postnatal ETS exposuree (þ) 142/311 [46] 136/353 [39]
Seroatopyf (þ) 89/311 [29] 46/186 [25]
Total IgE (Z50 IU/mL) 136/291 [47] 62/175 [35]
Current asthmag (þ) 61/311 [20] 33/182 [18]
Doctor diagnosed asthma (þ) 86/311 [28] 50/182 [28]
Asthma medication use (þ) 87/311 [28] 42/182 [23]
Recent wheezeh (þ) 87/311 [28] 40/182 [22]
Body mass indexi z score, median [SD] 0.63 [1.48] 0.85 [1.33]
Underweight (o5th percentile) 22/311 [7] 9/188 [5]
Normal weight (5th to o85th percentile) 172/311 [55] 98/188 [52]
Overweight (85th to o95th percentile) 54/311 [17] 35/188 [19]
Obesity (Z95th percentile) 63/311 [20] 46/188 [25]
Air monitor set up at age 5 yearsj 224/311 [72] 63/97 [65]
Prenatal pyrene median [range], ng/m³ 2.53 [0.77–17.2] 2.68 [0.28–97.0]
a None of the demographics differed significantly between the children included when compared to those excluded.
b Includes participants who underwent residential monitoring and had questionnaire data collected at age 5 years.
c Due to missing data. N¼319 CCCEH subjects did not undergo childhood air monitoring study, n¼35 had no BMI data available, n¼10 had no questionnaire data
obtained, n¼28 had invalid prenatal or age 5 PAH data, n¼4 had missing covariates, n¼19 had missing specific indoor IgE data and n¼2 had invalid BC and PM2.5 data.
d Prenatal ETS exposure was defined as the report of any smoker in the house during pregnancy.
e Postnatal ETS was defined as the report of any smoker in the house when the child was aged 6 months, 1, 2, 3 or 5 years.
f At least one specific IgEZ0.35 IU/mL to any of five indoor allergens tested at age 5.
g Current asthma defined as parental report of doctor diagnosis of asthma and taking asthma medication in the last 12 months at age 5.
h Recent wheeze defined as any report of wheeze in the past 12 months at age 5.
i Body mass index (BMI) calculated by weight (kg)/height (m)2, SD, standard deviation.
j Whether residential monitoring conducted at age 5 vs. 6 years.
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be a risk factor for childhood overweight or obesity (Gibson et al.,
2007). Our finding was supported further by the RERI analyses
showing a significant greater than additive interaction. We did not
observe a main effect of obesity on asthma, possibly due to the
fairly small sample size compared to other studies that have
examined the association or differences in cohort characteristics
(Castro-Rodriguez et al., 2001; Gilliland et al., 2003; Visness et al.,
2010). A similar effect modification by obesity was found at a later
age, suggesting that the effects of PAH-obesity on asthma may
persist through age 7. However, given the wide confidnece inter-
vals seen at age 7, these results should be interpreted with caution.
Additionally, the results from the tertile analysis of
9-methylphenanthrene and 3,6-dimethylphenanthrene conin-
cided well with the main findings (e-Table 3), providing further
confidence that the previously observed assocations were not
driven by outliers. Nevertheless, the second tertile of other
semivolatile PAH concentrations (e.g., phenanthrene, 1-methyl-
phenenthrene, 2-methylphenanthrene), but not the third tertile,
compared with the first tertile of concentration, was significantly
associated with asthma in obese children, suggesting a non-linear
dose-response relationship. We have no clear explanation for this
but it could be partly due to the complexity of PAH mixtures
relating to differences in volatility, bioaccumulation, toxicity and
emission sources among individual components (National Park
Service, 2013; Saha et al., 2009; Wolinska et al., 2011). Moreover,
given the positive association between repeated pyrene exposure
during prenatal and early childhood and asthma in our previous
publication (Jung et al., 2012b), we reexamined for an interaction
between repeated pyrene and obesity on asthma; no significant
interaction was found in these analyses (data not shown). Our results
also suggested a significant positive interaction between exposure to
methylphenanthrenes and obesity on asthma that was more pro-
nounced among nonatopic children (e-Table 4) or girls (e-Table 5).
This observation is supported by other epidemiological findings
showing air pollution (e.g. elemental carbon, particulate matter
PAH)-associated asthma (Epstein et al., 2012; Jung et al., 2012b)
and obesity-associated asthma (Gilliland et al., 2003; Visness et al.,
2010) is more common in nonatopic individuals. Thus, we speculate
that PAH-obesity related asthma may not necessarily be mediated by
allergic inflammation but that other nonallergic pathways may play
an important role. Also, our findings seem consistent with those from
the longitudinal Tucson Children's Respiratory Study that indicated
that the association between overweight/obesity and respiratory
symptoms was largely restricted to school-age girls (Castro-
Rodriguez et al., 2001).
Few cross-sectional studies have attempted to investigate effect
modification of the association between air pollution and asthma
by obesity. In one study of 904 elderly men, 48-hour higher levels
of O3 were associated with a greater decline in FEV1 in the obese
than in the non-obese (Alexeeff et al., 2007). A recent study with
asthmatic individuals 65 years or older also reported that the
mean daily concentration of elemental carbon (EC) was associated
with poorer asthma control based on Asthma Control Question-
naire (ACQ) scores among obese, but not among non-obese
asthmatics, suggesting that obesity may modify the effect of EC
on asthma exacerbations (Epstein et al., 2012). Similarly, in a study
with urban asthmatic children, overweight or obese children had
increased odds of respiratory symptoms associated with higher
levels of indoor PM2.5 and nitrogen dioxide (NO2) (Lu et al., 2013).
Our study adds new evidence to support that obese young
children are more prone to the effects of airborne PAH, methyl-
phenanthrenes in particular, that are mostly generated from
indoor sources on asthma at ages 5 and 7 years.
Despite these epidemiologic observations, the responsible biolo-
gical mechanisms are not well-understood. A recent study conducted
in mice has suggested that inhibition of the adipose derived hormone
important in appetite and metabolism, leptin, increases parasympa-
thetic signaling through the M3 muscarinic receptor in airway
smooth muscle cells (Arteaga-Solis et al., 2013). This mechanism
may thereby decrease bronchial diameter without affecting local
inflammation in the bronchi, leading to bronchoconstriction and
airway obstruction that could worsen in the setting of other asthma
triggers like air pollution (Arteaga-Solis et al., 2013).
An alternative explanation may be that a sedentary lifestyle in
obese children effectively indicates more time spent indoors
where substantial semivolatile PAH sources are present, thereby
increasing their exposure to asthma-promoting PAH. While this
particular study was not designed to measure time indoors, other
studies have shown that children at ages 5–7 years spend 65–68%
of their time indoors at home (Hubal et al., 2000), and obese
children tend to be physically less active and possess a more
sedentary lifestyle with excessive television watching or video
game use (Tremblay and Willms, 2003). Also, in an animal study,
Shore and colleagues reported that obese mice inhaled the greater
dose of O3 to the lungs than normal-weight mice due to higher
breathing frequency (Shore et al., 2003). Therefore, not only
increased time spent indoors but also higher breathing frequency
may lead obese children to be exposed to greater doses of asthma-
promoting methylphenanthrenes, compared to non-obese children.
A significant association of PAH with asthma but not recent
wheeze among obese children was observed. One interpretation is
that asthmatic children using asthma medications (inhaled corticos-
teroids, beta 2 adrenergic agonists) would be less symptom-
atic following air pollution exposure and report less wheeze and
Age 5-6 PAHs
N=408

























Fig. 1. Schematic demonstration of study data structure.
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potentially bias the results. Sensitivity analyses for children without
ICS revealed that a positive interaction remained although the
associations between exposure to methylphenanthrenes and asthma
were somewhat weakened (changes in RR ranged between 17% and
24%) among obese children, compared to those reported in main
analysis.
We acknowledge several limitations. First, the sample size is
fairly small, especially for stratified analyses by obesity status.
Second, many analyses were conducted on children with asthma
diagnosed through age 5, as opposed to incident asthma at age 5.
To account for the temporality between the exposure and the
outcome, we performed sensitivity analyses that excluded chil-
dren with a preexisting doctor diagnosis of asthma before age 5.
A significant interaction (PAH by obesity) was detected for most of
the semivolatile PAH (e-Table 6), although the statistical power of
the stratified analyses was limited. Also, only 72% of residential
monitorings were conducted at age 5 years when asthma out-
comes were measured. However, we controlled for age at time of
indoor monitoring in the model to address this latter limitation.
While the results were quite consistent when obesity was replaced
Table 2
Associations between age 5–6 years PAH concentrations and asthma at age 5 years: effect modification by obesity.
Total sample main effect Effect of age 5–6 PAH: stratified by obesity Multiplicative interaction modelc
(n¼311) Obese (n¼63) Non-obese (n¼248) (n¼311)
Age 5–6 PAH [IQRln] Adjusteda RR [95% CI] Adjusteda RR [95% CI] Adjusteda RR [95% CI] p-Value for interaction
Phe [0.77] 0.89 [0.67–1.17] 0.83 [0.48–1.44] 0.80 [0.58–1.11] 0.073
Obesity 1.18 [0.68–2.04]
1-Meph [0.76] 1.09 [0.80–1.48] 2.62n [1.17–5.88] 0.92 [0.65–1.31] 0.012
Obesity 1.20 [0.70–2.06]
2-Meph [0.73] 0.98 [0.74–1.30] 0.93 [0.46–1.87] 0.92 [0.68–1.23] 0.285
Obesity 1.18 [0.69–2.03]
3-Meph [0.74] 0.99 [0.76–1.30] 1.27 [0.67–2.42] 0.92 [0.68–1.23] 0.090
Obesity 1.18 [0.69–2.04]
9-Meph [0.73] 1.02 [0.77–1.35] 2.17n [1.06–4.45] 0.91 [0.69–1.20] 0.028
Obesity 1.19 [0.69–2.05]
1,7-DMeph [0.71] 0.94 [0.73–1.22] 1.05 [0.69–1.61] 0.92 [0.65–1.28] 0.573
Obesity 1.15 [0.66–2.03]
3,6-DMeph [0.71] 1.02 [0.73–1.41] 2.69n [1.21–5.94] 0.88 [0.60–1.29] 0.077
Obesity 1.19 [0.69–2.05]
Pyrene [0.56] 0.88 [0.67–1.16] 0.93 [0.44–1.95] 0.81 [0.59–1.12] 0.025
Obesity 1.19 [0.69–2.06]
∑8PAHsemivolatile [0.74] 0.91 [0.69–1.20] 0.87 [0.50–1.53] 0.82 [0.60–1.12] 0.069
Obesity 1.18 [0.68–2.03]
∑8PAHnonvolatile [1.02]b 0.81 [0.54–1.23] 0.84 [0.33–2.09] 0.74 [0.46–1.18] 0.089
Obesity 1.10 [0.62–1.94]
Relative risks (RR) are presented for an interquartile range (IQR) increase in each natural log-transformed PAH concentration.np-Valueo0.05. Note that there was no
observed association between PAHs and recent wheeze in stratified models by presence/absence of obesity.
a Model adjusted for ethnicity, sex, maternal education, maternal asthma, prenatal ETS, postnatal ETS, cold/flu season, residential monitoring conducted at age 5 vs.
6 years, heating season, seroatopic, prenatal pyrene, PM2.5 and BC. ∑8PAHsemivolatile includes phenanthrene (Phe), 1-methylphenanthrene (1Meph), 2-methylphenanthrene
(2Meph), 3-methylphenanthrene (3Meph), 9-methylphenanthrene (9Meph), 1,7-dimethylphenanthrene (1,7DMeph), 3,6-dimethylphenanthrene (3,6DMeph), and pyrene
and Σ8PAHnonvolatile includes benz[a]anthracene (BaA), chrysene/iso-chrysene (Chry), benzo[b]fluoranthene (BbFA), benzo[k]fluoranthene (BkFA), benzo[a]pyrene (BaP),
indeno[1,2,3-c,d]pyrene (IP), dibenz[a,h]anthracene (DahA), and benzo[g,h,i]perylene (BghiP).
b Adjusted for prenatal Σ8PAHnonvolatile instead of prenatal pyrene.






















Fig. 2. Effect modification of obesity on the association between childhood PAH
measures and current asthma at age 5 years. n§: Cases of current asthma and N:
total sample size; relative risk estimates of asthma for an interquartile increase in
log 1-methylphenanthrene (1Meph), 3-methylphenanthrene (3Meph), and 3,6-
dimethylphenanthrene (3,6DMeph) concentrations among obese (n¼63) and
nonobese (n¼248) children, adjusting for ethnicity, sex, maternal education,
maternal asthma, prenatal ETS, childhood ETS, cold/flu season, residential monitor-
ing conducted at age 5 vs. 6 years, heating season, seroatopic, prenatal pyrene,





















Fig. 3. Effect modification of obesity on the association between childhood PAH
exposure and current asthma at age 7 years. n§: Cases of current asthma and N:
total sample size; relative risk estimates of asthma for an interquartile increase in
log 3-methylphenanthrene (3Meph), 9-methylphenanthrene (9Meph), and 3,6-
dimethylphenanthrene (3,6DMeph) concentrations among obese (n¼53) and
nonobese (n¼205) children, adjusting for ethnicity, sex, maternal education,
maternal asthma, prenatal ETS, childhood ETS, cold/flu season, residential monitor-
ing conducted at age 5 vs. 6 years, heating season, seroatopic, prenatal pyrene,
PM2.5 and BC; Pinteraction: p-values for multiplicative interaction; nnpo0.01.
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with continuous BMI z score, an interaction effect was attenuated
after the exclusion of the upper or lower 5% of PAH measures.
Lastly, collection of physical time-activity information during
sampling periods would have helped assess whether sedentary
lifestyle or increased time spent indoors contributed significantly.
5. Conclusion
This study offers the first evidence that obesity may modify
the effect of age 5–6 years PAH exposure, and the semivolatile
methylphenanthrenes in particular, on asthma in young children
at ages 5 and 7 years. These results suggest that obesity may
enhance the vulnerability to effects of age 5–6 years PAH exposure
on airway outcomes, particularly for nonatopic children and for
girls. Specific interventions aimed at reducing PAH exposure and
preventing excessive weight gain or increasing vigorous physical
activity for young children living in the inner city should be
evaluated as valuable tools in preventing adverse respiratory
outcomes during childhood.
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P value for positivea interactions between age 5–6 years PAH concentrations and
body mass index (BMI)b z score on asthma at ages 5 and 7 years.
p-Value for interactionc (PAHBMI z score) on asthma











a Positive interaction defined as RR for multiplicative interaction greater than 1.
b Weight (kg)/height (m)2.
c Multiplicative interaction model adjusted for ethnicity, sex, maternal educa-
tion, maternal asthma, prenatal ETS, postnatal ETS, cold/flu season, residential
monitoring conducted at age 5 vs. 6 years, heating season, seroatopic, prenatal
pyrene, PM2.5 and BC. ∑8PAHsemivolatile includes Phe, 1Meph, 2Meph, 3Meph,
9Meph, 1,7DMeph, and 3,6DMeph, and pyrene and Σ8PAHnonvolatile includes BaA,
Chry, BbFA, BkFA, BaP, IP, DahA, and BghiP.
d Adjusted for prenatal Σ8PAHnonvolatile instead of prenatal pyrene.
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